Total Funding
67
53
Total FundingPost-IPO Equity raised
Growth Score
-21 pts
Heat Score
-29 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
91565
Dermata Therapeutics is a biotechnology firm that focuses on advancements in the treatment of serious diseases treated by dermatologists.
- David Hale: Co-Founder and Managing DirectorPast Role: Women First HealthCare, Inc., President and CEO
Gerald Proehl: Founder, President, CEO & DirectorPast Role: Santarus, President & CEO (Previously VP Marketing, Business Development)
About the Company
Dermata is a development-stage biotechnology company that focuses on making major advancements in the treatment of serious diseases treated by dermatologists. Its business strategy is to identify and develop innovative products that move into clinical trials to demonstrate efficacy and safety in a variety of diseases. They currently exploring the
use of a unique botanical product with multiple proposed mechanisms of action in order to treat acne.
It was founded in 2014 and headquartered in Encinitas, California.
